Evidence map›Paper›PMID 39839033›Full record

ArticleQuantitative imaging in medicine and surgery2025

Brain tumor enhancement prediction from pre-contrast conventional weighted images using synthetic multiparametric mapping and generative artificial intelligence.

Elisa Moya-Sáez, Rodrigo de Luis-García, Laura Nunez-Gonzalez, Carlos Alberola-López, Juan Antonio Hernández-Tamames

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elisa Moya-SáezImage Processing Lab, University of Valladolid, Valladolid, Spain.ORCID https://orcid.org/0000-0003-4945-3193
Rodrigo de Luis-GarcíaImage Processing Lab, University of Valladolid, Valladolid, Spain.ORCID https://orcid.org/0000-0001-5023-6490
Laura Nunez-GonzalezRadiology and Nuclear Medicine Department, Erasmus MC, Rotterdam, The Netherlands.
Carlos Alberola-LópezImage Processing Lab, University of Valladolid, Valladolid, Spain.ORCID https://orcid.org/0000-0003-3684-0055
Juan Antonio Hernández-TamamesRadiology and Nuclear Medicine Department, Erasmus MC, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gadolinium-based contrast agents (GBCAs) are usually employed for glioma diagnosis. However, GBCAs raise safety concerns, lead to patient discomfort and increase costs. Parametric maps offer a potential solution by enabling quantification of subtle tissue changes without GBCAs, but they are not commonly used in clinical practice due to the need for specifically targeted sequences. This work proposes to predict post-contrast T1-weighted enhancement without GBCAs from pre-contrast conventional weighted images through synthetic parametric maps computed with generative artificial intelligence (deep learning). Methods: In this retrospective study, three datasets have been employed: (I) a proprietary dataset with 15 glioma patients (hereafter, GLIOMA dataset); (II) relaxometry maps from 5 healthy volunteers; and (III) UPenn-GBM, a public dataset with 493 glioblastoma patients. A deep learning method for synthesizing parametric maps from only two conventional weighted images is proposed. Particularly, we synthesize longitudinal relaxation time (T1), transversal relaxation time (T2), and proton density (PD) maps. The deep learning method is trained in a supervised manner with the GLIOMA dataset, which comprises weighted images and parametric maps obtained with magnetic resonance image compilation (MAGiC). Thus, MAGiC maps were used as references for the training. For testing, a leave-one-out scheme is followed. Finally, the synthesized maps are employed to predict T1-weighted enhancement without GBCAs. Our results are compared with those obtained by MAGiC; specifically, both the maps obtained with MAGiC and the synthesized maps are used to distinguish between healthy and abnormal tissue (ABN) and, particularly, tissues with and without T1-weighted enhancement. The generalization capability of the method was also tested on two additional datasets (healthy volunteers and the UPenn-GBM). Results: Parametric maps synthesized with deep learning obtained similar performance compared to MAGiC for discriminating normal from ABN (sensitivities: 88.37% Conclusions: Our results suggest the feasibility to predict T1-weighted-enhanced tissues from pre-contrast conventional weighted images using deep learning for the synthesis of parametric maps.

Indexed as

brain tumorsdeep learning (DL)Enhancement predictiongadolinium-based contrast agents (GBCAs)synthetic magnetic resonance imaging (synthetic MRI)

Identifiers

PMID39839033
PMCPMC11744120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.